408-854-1883 starts at $30 per hr home care

Marketplace

Soon

408-854-1883 text

Marketplace

Soon

Book an Appointment

Affordable in home care | starts at $28 per hr

Pharmacogenetic tests to avoid 70% drug related adverse events

Who needs pharmacogenetic tests?

Seniors, those taking more than 2 medications for pain, heart, kidney, in cancer therapy, anyone who is sensitive to medications/drugs and as prescribed by primary care doctors or specialists (OBs, oncologists, pain docs, pharmacy-based providers).

Doctors have a checklist/panels for pharmacogenetic tests

  • Pain
  • Cardiac
  • Mental health
  • Polypharmacy

 

Aging

Advancing age is characterized by impairment in the function of the many regulatory processes that provide functional integration between cells and organs. Therefore, there may be a failure to maintain homeostasis under conditions of physiological stress. The reduced homeostatic ability affects different regulatory systems in different subjects, thus explaining at least partly the increased interindividual variability occurring as people get older. Important pharmacokinetic and pharmacodynamic changes occur with advancing age. Pharmacokinetic changes include a reduction in renal and hepatic clearance and an increase in volume of distribution of lipid soluble drugs (hence prolongation of elimination half-life) whereas pharmacodynamic changes involve altered (usually increased) sensitivity to several classes of drugs such as anticoagulants, cardiovascular and psychotropic drugs. This review focuses on the main age-related physiological changes affecting different organ systems and their implications for pharmacokinetics and pharmacodynamics of drugs.

Heart

Ageing produces major cardiovascular changes, including reduced elasticity and compliance of the aorta and great arteries [3]. This results in a higher systolic arterial pressure, increased impedance to left ventricular ejection, and subsequent left ventricular hypertrophy and interstitial fibrosis [4]. A decrease in the rate of myocardial relaxation also occurs. The left ventricle becomes stiffer and takes longer to relax and fill in diastole, thus increasing the importance of a properly timed atrial contraction in contributing to a normal left ventricular end-diastolic volume [5]. The isotonic contraction is prolonged and velocity of shortening reduced.

Renal mass decreases with age [10]. This reflects the reduction in nephrons [11]. Intra-renal vascular changes also occur, consisting of hyalinization of the vascular tuft leading to reduced blood flow in the afferent arterioles in the cortex [12]. No changes in the medullary vasculature are reported with ageing [13]. Both renal plasma flow and glomerular filtration rate decline with age. The decline is not uniform or consistent, however, [14, 15]. Despite the decline in glomerular filtration rate, there is no concomitant increase in plasma creatinine because of age-related loss of muscle mass. T.

Liver

Advancing age is associated with a progressive reduction in liver volume and liver blood flow [31]. Alteration of hepatic structure and enzymatic functions with ageing is moderate. In the healthy elderly person, routine tests of liver function involving the metabolism and elimination of specific dyes, radioisotopes, and protein synthesis do not show significant differences between individuals aged 50–69 and 70–89 years

herefore, creatinine is not a reliable indicator of glomerular filtration rate in the elderly subject. Other markers such as serum cystatin C do not provide significant advantages over creatinine for the measurement of creatinine clearance.

Neuroendocrine responses

Ageing is accompanied by changes in neuroendocrine responses to psychosocial or physical stress. In particular, an altered function of the hypothalamic-pituitary-adrenal (HPA) axis has been observed. Excessive HPA activation and hypersecretion of glucocorticoids can lead to dendritic atrophy in neurones in the hippocampus, resulting in learning and memory impairment. Damage or loss of hippocampal neurones results in impaired feedback inhibition of the HPA axis and glucocorticoid secretion, leading to further damage caused by elevated glucocorticoid concentrations. This positive feedback effect on hippocampal neuronal loss is known as the glucocorticoid cascade hypothesis [34]. Thus, glucocorticoids may sensitize hippocampal neurones to cell death and/or functional impairment, indirect effects that are likely to be age-dependent.

First-pass metabolism and bioavailability

Ageing is associated with a reduction in first-pass metabolism. This is probably due to a reduction in liver mass and blood flow [52]. As a result, the bioavailability of drugs undergoing extensive first-pass metabolism such as propranolol and labetalol can be significantly increased [53–55]. On the other hand, several ACE inhibitors such as enalapril and perindopril are pro-drugs and need to be activated in the liver. Therefore, their first-pass activation might be slowed or reduced with advancing age.

Drug distribution

As a consequence of the age-related changes in body composition [36], polar drugs that are mainly water-soluble tend to have smaller volumes of distribution (V) resulting in higher serum levels in older people. Gentamicin, digoxin, ethanol, theophylline, and cimetidine fall into this category [58–60]. Loading doses of digoxin need to be reduced to accommodate these changes [60]. On the other hand, nonpolar compounds tend to be lipid-soluble and so their V increases with age. The main effect of the increased V is a prolongation of half-life. Increased V and t1/2 have been observed for drugs such as diazepam, thiopentone, lignocaine, and chlormethiazole [61–66].

Protein binding

Acidic compounds (diazepam, phenytoin, warfarin, salicylic acid) bind principally to albumin whereas basic drugs (lignocaine, propranolol) bind to α1-acid glycoprotein. Although no substantial age-related changes in the concentrations of both these proteins have been observed [33, 67], albumin is commonly reduced in malnutrition or acute illness whereas α1-acid glycoprotein is increased during acute illness.

Drug clearance

Kidney

Reduction in renal function in elderly subjects, particularly glomerular filtration rate, affects the clearance of many drugs such as water-soluble antibiotics [69, 70], diuretics [71], digoxin [72], water-soluble β-adrenoceptor blockers [73], lithium [74], and nonsteroidal anti-inflammatory drugs [75, 76]. The clinical importance of such reductions of renal excretion is dependent on the likely toxicity of the drug. Drugs with a narrow therapeutic index like aminoglycoside antibiotics, digoxin, and lithium are likely to have serious adverse effects if they accumulate only marginally more than intended. However, a recent study has questioned the importance of age-related reduction in renal function in affecting pharmacokinetics. Although creatinine clearance was slightly reduced in healthy elderly subjects, excretion of atenolol, hydrochlorothiazide and triamterene was similar to young subjects.

Congestive heart failure

Studies investigating possible age-related differences in cardiovascular function in patients with congestive heart failure show a progressive decrease in heart rate and an increase in systemic vascular resistance in older patients [97]. This is associated with increased plasma noradrenaline and serum creatinine concentrations [97]. The therapeutic implications of some pharmacokinetic changes involving the main agents used for the treatment of this condition are discussed.

Digoxin

Digoxin is well absorbed in the gastrointestinal tract. However, the time to peak plasma concentrations is prolonged with advancing age from a mean of 38 h in younger subjects to 69 h in elderly subjects [60]. Therefore, the time to reach steady-state plasma concentrations increases from 7 to 12 days in elderly subjects. The volume of distribution is decreased in elderly patients. As a result, loading doses should be reduced by approximately 20%[60].

Because digoxin is cleared mainly through the kidneys and digoxin clearance is proportional to creatinine clearance [98], the systemic clearance of digoxin is reduced with age [60]. As clearance is the main determinant of the maintenance dose, the daily dose of digoxin should be reduced. This should be guided by renal function and body weight.

Diuretics

Several studies investigated the effect of ageing on the pharmacokinetics of frusemide administered intravenously [99, 100]. The volume of distribution was similar in older subjects as compared with younger individuals. This was associated with a reduced renal clearance and a prolonged half-life in elderly subjects [99, 100]. The reduced effects of frusemide with ageing seem to be due mainly to a decrease in tubular secretion. The latter may be caused by a reduction in renal plasma flow.

A slight reduction in the renal clearance of thiazide diuretics and triamterene, alone or in combination, has also been observed with advancing age [101, 102]. The latter findings have been disproved by a recent study [77].

ACE inhibitors

Some of the drugs of this class are active compounds (i.e. lisinopril) but most are pro-drugs undergoing activation in the liver (i.e. enalapril, perindopril). This biotransformation might be impaired in patients with severe heart failure and hepatic congestion. Most of the ACE inhibitors are excreted through the kidney by glomerular filtration and tubular secretion. In the presence of renal impairment their plasma concentration increases

Top 5 active and healthiest cities in the USA

It turns out that wintery Boston and its surrounding suburbs have earned the title of being the top “active living community” in the U.S., as a result of investments in public areas like bike lanes and parks, according to the report published today by Gallup.

The top five cities included three East Coast metro areas, one Midwest and one West Coast city.

1. Boston–Cambridge–Newton, MA–NH

2. San Francisco–Oakland–Hayward, CA

3. Chicago–Naperville–Elgin, IL–IN–WI

4. New York–Newark–Jersey City, NY–NJ–PA

5. Washington–Arlington–Alexandria, DC–VA–MD–WV

The lowest scorers included metro areas in the South and Midwest, including Fort Wayne, Indianapolis, Oklahoma City and Tulsa. Cities with the lowest scores were found to have higher rates of negative health conditions including depression, obesity, diabetes, hypertension, high cholesterol and smoking.

Doctors better than Google

(Reuters Health) – Doctors are much better than symptom-checker programs at reaching a correct diagnosis, though the humans are not perfect and might benefit from using algorithms to supplement their skills, a small study suggests.

In a head-to-head comparison, human doctors with access to the same information about medical history and symptoms as was put into a symptom checker got the diagnosis right 72 percent of the time, compared to 34 percent for the apps.

The 23 online symptom checkers, some accessed via websites and others available as apps, included those offered by Web MD and the Mayo Clinic in the U.S. and the Isabel Symptom Checker in the U.K.

“The current symptom checkers, I was not surprised do not outperform doctors,” said senior author Dr. Ateev Mehrotra of Harvard Medical School in Boston.

Personalize Med ebook by Priya Hays

priya

The book provides a unique perspective on the biomedical and societal implications of personalized medicine for patients through case studies, expert interviews, patient narratives and detailed technical descriptions. It presents an overview of what personalized medicine will do for the clinic and how it will help mitigate the healthcare crisis, with a focus on proactive predictive healthcare as opposed to reactive trial by error healthcare.

Increased air pollution, more ER hospital visits

Respiratory Disease

As an approach to evaluating the public health burden from current air pollution levels, we examined the relationship of daily emergency room (ER) visits for respiratory illnesses (25 hospitals, average 98 visits/d) to air pollution in Montreal, Canada, from June through September, 1992 and 1993. Air pollutants measured included ozone (O3), particulate matter diameter < 10 microm (PM10) and < 2.5 microm (PM2.5), the sulfate fraction of PM2.5 (SO4), and aerosol strong acidity (H+). Temporal trends, autocorrelation, and weather were controlled for in time-series regressions.

For 1992, no significant associations with ER visits were found. However, 33% of the particulate data were missing. For 1993, 1-h maximum O3, PM10, PM2.5, and SO4 were all positively associated with respiratory visits for patients over 64 yr of age (p < 0.02). An increase to the mean level of 1-h maximum O3 (36 ppb) was associated with a 21% increase over the mean number of daily ER visits (95% confidence interval [CI]: 8 to 34%). Effects of particulates were smaller, with mean increases of 16% (4 to 28%), 12% (2 to 21%) and 6% (1 to 12%) for PM10, PM2.5, and SO4, respectively. Relative mass effects were PM2.5 > PM10 >> SO4. Ozone and PM10 levels never exceeded 67 ppb and 51 microg/m3, respectively (well below the U.S. National Ambient Air Quality Standards of 120 ppb and 150 microg/m3, respectively). The present findings have public health implications with regard to the adverse health effects of urban photochemical air pollution on older individuals.

https://www.ncbi.nlm.nih.gov/pubmed/9032196

A total of 92,464 respiratory emergency visits were recorded during the study period. The mean daily PM2.5 concentration was 102.1±73.6 μg/m3. Every 10 μg/m3 increase in PM2.5concentration at lag0 was associated with an increase in ERV, as follows: 0.23% for total respiratory disease (95% confidence interval [CI]: 0.11%-0.34%), 0.19% for upper respiratory tract infection (URTI) (95%CI: 0.04%-0.35%), 0.34% for lower respiratory tract infection (LRTI) (95%CI: 0.14%-0.53%) and 1.46% for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) (95%CI: 0.13%-2.79%). The strongest association was identified between AECOPD and PM2.5 concentration at lag0-3 (3.15%, 95%CI: 1.39%-4.91%). The estimated effects were robust after adjusting for SO2, O3, CO and NO2. Females and people 60 years of age and older demonstrated a higher risk of respiratory disease after PM2.5 exposure.

Conclusion

PM2.5 was significantly associated with respiratory ERV, particularly for URTI, LRTI and AECOPD in Beijing. The susceptibility to PM2.5 pollution varied by gender and age.

http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0153099

 

Heart Disease

In this large multicenter analysis, daily average concentrations of CO and NO2 exhibited the most consistent associations with ED visits for cardiac conditions, while ozone exhibited the most consistent associations with visits for respiratory conditions. PM10 and PM2.5 were strongly associated with asthma visits during the warm season.

https://ehjournal.biomedcentral.com/articles/10.1186/1476-069X-8-25

Training the brain not to be racist or sexist

Exercising the cingulate cortex is only the start. The Brown University study is a new entry in an increasingly fertile field of science about how we can alter the brain’s responses to try and rewire, shift, and disable implicit biases, preventing racist responses and creating a more racially harmonious world. Glass-half-full thinking? Maybe, but as we’ll see, the science behind it is solid, if complex.

A study in 2015 showed that implicit bias, both racial and sexual, can be targeted in another way: through sleep training. Participants were given “counter-bias training,” where faces were shown with non-stereotypical words beside them (black faces, for instance, had positive words like “sunshine”) while certain distinctive sounds played. When those sounds were played again, at an unobtrusive volume, during the participants’ afternoon naps, they showed that the effects stuck: they associated the positive words with the pictures more readily. This sort of approach is gaining increasing popularity; the Washington Post reported in August that the Justice Department is attempting to instal implicit bias training across multiple levels in response to evidence of racial prejudice in the nation’s police force (though some people are a bit skeptical about whether it will work).

There are other methods, but they haven’t necessarily met with great success. One much-hyped idea was to artificially increase empathy,making people sympathize with those of other races through stories or movies; but The Atlantic reported in July that researchers had found these measures didn’t have great success, with one notable exception. If white participants were read stories in which they were being attacked by a vicious white person and saved by a valiant, heroic black person, their implicit bias scores plummeted; but without the vicious white villain, the story had little to no effect.

Neck pain and MTHFR gene , folate , methionine

This slideshow requires JavaScript.

My co-worker complained of chronic neck pain and her doctor prescribed a med and an iron pill. My mom uses Zyflamend in evening (with calcium and magnesium supplement in 60:40 ratio with Vit D, zinc and C) and iron rich food for lunch and avoided inflammatory foods such as red meat and eggplant.  I suggested a massage stroke (using the thumb in one downward motion from neck to back) and oil mixed with eucalyptus, tea tea oil and apricot oil.  A Fluradix liquid iron supplement with whole foods in the morning will also help, including raisins,liver,dark chocolate and blackstrap mollases.  A chronic pain is indicative of a deep rooted health issue that must be addressed at the core. There genes that affect how we absorb iron. Vit C rich foods and vinegar help in the absorption of iron (eaten in the morning and noon) and calcium (eaten in the evening because iron and calcium cancels each other).  I will always add probiotics and prebiotics in this health issue.

  1. Avoid taking folic acid blocking or depleting drugs, such as birth control pills or Methyltrexate
  2. Avoid taking proton pump inhibitors, like Prilosec or Prevacid or antacids, like Tums, which may block essential Vitamin B12 absorption
  3. Have your homocysteine measured, which if elevated may indicate a problem with methylation or a deficiency of B12 or folate.  If your homocysteine is elevated, limit your intake ofmethionine-rich foods
  4. Avoid eating processed foods, many of which have added synthetic folic acid.  Instead eat whole foods with no added chemicals or preservatives.
  5. Get your daily intake of leafy greens, like spinach, kale, swiss chard or arugula, which are loaded with natural levels of folate that your body can more easily process.
  6. Eat hormone-free, grass-fed beef, organic pastured butter or ghee, and eggs from free-range, non-GMO fed chickens.
  7. Remove any mercury amalgams with a trained biologic dentist.  Avoid aluminum exposure in antiperspirants or cookware.  Avoiding heavy metal or other toxic exposure is important.
  8. Make sure you supplementing with essential nutrients, like methyl-B12, methyl-folate, TMG, N-acetylcysteine, riboflavin, curcumin, fish oil, Vitamins C, D, E, and probiotics.  If you are double homozygous for MTHFR mutations, you should proceed very cautiously with methyl-B12 and methyl-folate supplementation as some people do not tolerate high doses.  Introduce nutrients one by one and watching for any adverse reactions.  Use extreme caution when supplementing with niacin, which can dampen methylation.
  9. Make time for gentle detox regimens several times per week.  These could include infrared sauna, epsom salt baths, dry skin brushing, and regular exercise or sweating.

See MTHFR gene mutation, iron and neck pain

methio 4.JPG

Inner cities in the USA are thriving

inner.JPG

house-price-2house-price-1

What do you think are factors that show that inner cities are thriving?

← Back

Thank you for your response. ✨

Be a new mom, abortion, Republican, Democrat, faith, top election voices

pregnant-at-20

Dear fellow American women,

My 20 yr old daughter said that it is common sense to put a person in a job with all the qualifications needed to do the job. In terms of voting for the USA president, I am with her not because she is a woman but because of her qualification. We must admit, she worked hard for over 30 years and co-wrote 400+ policies in the Senate. We should not be jealous of another woman’s accomplishments. Our goal is health care, sensible with the positive gains of OBAMACARE and a fix to it, to put limits to how much the pharma and health insurance companies want to increase their profit.

I am for abortion not because I am not a Christian. I am a Catholic and will always will be.Took 12 units of Theology class, goes to say the rosary for an hour every Saturday and joined a procession , bringing the image of mother Mary house to house.  I believe that women should have the right to decide about their bodies. In the olden times, women die on the street without proper care during a clothes hanger abortion or similar non-sterile operation.

When my 19 yr son old started dating, I drove him to Planned Parenthood.

I love helping young women how to nurture their pregnancy and babies with childbirth education as an educator and how to massage babies, and other wellness ways.

We all wish that we can leave our future generation with their own set of rules, not limited by our own judgement of a woman president or party. That the future generation of women will not be sexually assaulted, physically or verbally by any man in power or not in power. That the future grandchildren will have less student loans than us. That the future retirees will have enough to live by and still enjoy the  community, health care  and necessities in life.

We are blessed to have lived in this country, USA, where we can learn new ways, try new business and explore the world with peace and prosperity.

If we can only be not judgemental, as only God can judge if we decide to abort, to support a woman President, to support a Republican or Democratic party or be loyal to our abusive husbands and/or partners. Please do not vote for a party just because your partner wants to. Vote because you believe that women have the power to change the world, without booing or shouting to another person or party.

Blessings,

Connie Dello Buono

Election comments

PaulB

Cincinnati, Ohio 1 hour ago

Is there any doubt that Hillary Clinton is the most vilified public figure of this still young century? One national network has a mission to destroy her. The weird right wing conspiracy driven social media ecosystem (Brietbart, Adam Jones, Ann Coulter, etc all) hate her viscerally, as do many Members of Congress and a wide swath of the population.

is it any wonder that she is a private person in a public role? Can anyone really blame her or hold it against Clinton to shrink in a defensive crouch when he opponent asserts she is a devil who he would throw in jail? No one has been as subjected to such nonstop vitriolic abuse, and is, frankly, less deserving of the withering criticism. Benghazi? How many GOP inquiries that came up with nothing? Email server? Not one shread of evidence that national security was compromised, nor has anyone mentioned that Bush/Cheney destroyed more than 5,000,000 White House emails associated with the invasion of Iraq, the century’s seminal moment of political fraud?

I, for one, conclude that Trump was spot on about Hillary: she is tough, determined and focused. Are not those the qualities of a leader? Forget her less than sizzling persona. Ignore the lingering tides of sexism still awash in the country. HRC has absolutely been through the guantlet of public and personal challenges unlike any other public figure in my lifetime. i will enthusiastically cast my vote for Hillary next month. It’s time for steady, embracing, female leadership.

FunkyIrishman

Ireland 1 hour ago

C’mon Mark, there is nothing risky about Hillary Clinton.

All hyperbole aside, Secretary Clinton is the most qualified candidate for President by far. ( man OR woman ). She supports a centrist, quasi-corporatist platform with some slightly left of center policies ( maybe ) since being pulled over by Senator Sanders and the Sandernistas.

After, 30 years + of the political spectrum being pulled to the extreme right, that even old republican baked policies are declared ”socialist’, there is absolutely nothing risky about Secretary Clinton .

Now with the other guy, we could end as a civilization…

Al Reese

Washington 1 hour ago

What strikes me most from this exceptional piece of reporting is just how difficult it is for a person of substance, intellect, compassion and empathy to communicate those attributes in today’s media environment. And, in stark contrast, how easy it is to communicate the vapid, simplistic, hateful rhetoric spewed by her opponent. When I went through journalism school, a lot of the talk was about the Canadian, Marshall McCluhan’s prediction of the worldwide web, 30 years before it was actually invented. He was, of course, both prescient and prophetic: in the new age, he said, humans would move from individualism to what he called a “tribal base.” We are witnessing now the manifestation of his theories.

Bartleby33

Paris 1 hour ago

Although it would be completely insane to vote for Trump- and as an American abroad I have already cast my vote for Hillary Clinton-, this election carries not much hope to change the system. Mrs Clinton’s presidency will pretty much be the same as Mr. Obama’s unless she can coalesce with a Democratic congress to really change things and address grave domestic issues like increasing inequalities, continuing racism, imperfect and expensive health care system, dramatically high college tuitions, climate change…etc and the list is long. I must say that as an American living in Paris, I was horrified by the crass level of the debate which Trump instigated. By letting Trump win the nomination, the Republican party robbed the American people of a real election. In the existing circumstances, there is no choice at all but to vote for Mrs. Clinton. And this lack of proper choice is wounding our democracy.

Richard M. Waugaman, M.D.

Chevy Chase, MD 2 hours ago

Having been mesmerized by Hillary’s performance in the first two presidential debates, my opinion of her is soaring.

We know that the Hillary-ophobes have been brainwashed by years of Faux News and its barrage of untruths about her. But I am beginning to wonder if even those of us who support her have also been “brain-rinsed” a bit.

No, she is not perfect. But she is eminently qualified to serve as President, and our country is fortunate that she has the strength of character to withstand the years of disgustingly dishonest attacks on her.

comments Wsj.JPG

Volunteers Needed for Cancer Study

nih

https://www.cancer.gov/about-cancer/treatment/clinical-trials/nci-supported/nci-match

This phase II trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic material (genes) of patients’ tumor cells. Patients with genetic abnormalities (such as mutations, amplifications, or translocations) may benefit more from treatment which targets their tumor’s particular genetic abnormality. Identifying these genetic abnormalities first may help doctors plan better treatment for patients with solid tumors or lymphomas.

Eligibility Criteria

Inclusion Criteria

  • Women of childbearing potential must have a negative serum pregnancy test within 2 weeks prior to registration; patients that are pregnant or breast feeding are excluded; a female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: * Has not undergone a hysterectomy or bilateral oophorectomy; or * Has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
  • Women of childbearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 4 months after completion of study; should a woman become pregnant or suspect while she or her partner is participating in this study, she should inform her treating physician immediately
  • Patients must have histologically documented solid tumors or histologically confirmed diagnosis of lymphoma or multiple myeloma requiring therapy and that has progressed following at least one line of standard systemic therapy and/or for whose disease no standard treatment exists that has been shown to prolong survival * NOTE: No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer; in situ cervical cancer; adequately treated stage I or II cancer from which the patient is currently in complete remission; any other cancer from which the patient has been disease-free for 5 years
  • Patients must have measurable disease
  • Patients must meet one of the following criteria: * Patients must have tumor amenable to image guided or direct vision biopsy and be willing and able to undergo a tumor biopsy for molecular profiling; patients with multiple myeloma are to have a bone marrow aspirate to obtain tumor cells; biopsy must not be considered to be more than minimal risk to the patient * Patient will be undergoing a procedure due to medical necessity during which the tissue may be collected * Formalin-fixed paraffin-embedded (FFPE) tumor tissue block(s) are available for submission following pre-registration (not applicable for bone marrow aspirate specimens); criteria for the submission of FFPE tissue are: ** Tissue must have been collected within 6 months prior to pre-registration ** Patient has not received any intervening therapy that is considered to be targeted (e.g. against a particular or multiple molecular target) for their cancer since the collection of the tumor sample; they may have received cytoxic chemotherapy for up to 4 cycles, but must not have had response to such treatment ** Formalin-fixed paraffin-embedded tumor tissue block(s) must meet the minimum requirements
  • Patient must not require the use of full dose coumarin-derivative anticoagulants such as warfarin; low molecular weight heparin is permitted for prophylactic or therapeutic use; factor X inhibitors are permitted * NOTE: Warfarin may not be started while enrolled in the EAY131 study * Stopping the anticoagulation for biopsy should be per site standard operating procedure (SOP)
  • Patients must have Eastern Cooperative Oncology Group (ECOG) performance status =< 1 and a life expectancy of at least 3 months
  • Patients must not currently be receiving any other investigational agents
  • Patients must not have any uncontrolled intercurrent illness including, but not limited to: * Symptomatic congestive heart failure (New York Heart Association [NYHA] classification of III/IV) * Unstable angina pectoris or coronary angioplasty, or stenting within 6 months prior to registration * Cardiac arrhythmia (ongoing cardiac dysrhythmias of National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE] version [v]4 grade >= 2) * Psychiatric illness/social situations that would limit compliance with study requirements * Intra-cardiac defibrillators * Known cardiac metastases * Abnormal cardiac valve morphology (>= grade 2) documented by echocardiogram (ECHO) (as clinically indicated); (subjects with grade 1 abnormalities [i.e., mild regurgitation/stenosis] can be entered on study); subjects with moderate valvular thickening should not be entered on study * NOTE: To receive an agent, patient must not have any uncontrolled intercurrent illness such as ongoing or active infection; patients with infections unlikely to be resolved within 2 weeks following screening should not be considered for the trial
  • Patients must be able to swallow tablets or capsules; a patient with any gastrointestinal disease that would impair ability to swallow, retain, or absorb drug is not eligible
  • Patients who are human immunodeficiency virus (HIV)-positive are eligible if: * Cluster of differentiation (CD)4+ cell count greater or equal to 250 cells/mm^3 * If patient is on antiretroviral therapy, there must be minimal interactions or overlapping toxicity of the antiretroviral therapy with the experimental cancer treatment; for experimental cancer therapeutics with cytochrome P450 (CYP)3A4 interactions, protease inhibitor therapy is disallowed; suggested regimens to replace protease inhibitor therapy include dolutegravir given with tenofovir/emtricitabine; raltegravir given with tenofovir and emtricitabine; once daily combinations that use pharmacologic boosters may not be used * No history of non-malignancy acquired immune deficiency syndrome (AIDS)-defining conditions other than historical low CD4+ cell counts * Probable long-term survival with HIV if cancer were not present
  • Any prior therapy, radiotherapy (except palliative radiation therapy of 30 gray [Gy] or less), or major surgery must have been completed >= 4 weeks prior to start of treatment; registration to screening steps must occur after stopping prior therapy, and all adverse events due to prior therapy have resolved to a grade 1 or better (except alopecia and lymphopenia) by start of treatment; palliative radiation therapy must have been completed at least 2 weeks prior to start of treatment; the radiotherapy must not be to a lesion that is included as measurable disease * NOTE: Prostate cancer patients may continue their luteinizing hormone-releasing hormone (LHRH) agonist * NOTE: Patients may receive non-protocol treatment after biopsy (if clinically indicated) until they receive notification of results; the patient cannot enroll onto another investigational study as part of the interim therapy; the therapy cannot be an arm in the MATCH trial; the decision to stop the intermittent nonprotocol treatment will be left up to the treating physician if patient has an actionable mutation/amplification of interest (aMOI); however, patients will need to be off such therapy for at least 4 weeks before receiving any MATCH protocol treatment
  • Patients with brain metastases or primary brain tumors must have completed treatment, surgery or radiation therapy >= 4 weeks prior to start of treatment
  • Patients must have discontinued steroids >= 1 week prior to registration, except as permitted (see below), and remain off steroids thereafter; patients with glioblastoma (GBM) must have been on stable dose of steroids, or be off steroids, for one week prior to registration to treatment * NOTE: The following steroids are permitted: ** Temporary steroid use for computed tomography (CT) imaging in setting of contrast allergy ** Low dose steroid use for appetite ** Chronic inhaled steroid use ** Steroid injections for joint disease ** Stable dose of replacement steroid for adrenal insufficiency or low doses for non-malignant disease (prednisone 10 mg daily or less, or bioequivalent dose of other corticosteroid) ** Topical steroid
  • Leukocytes >= 3,000/mcL
  • Absolute neutrophil count >= 1,500/mcL
  • Platelets >= 100,000/mcL
  • NOTE: Patients with documented bone marrow involvement by lymphoma are not required to meet the above hematologic parameters, but must have a platelet count of at least 75,000/mcL and neutrophil count of at least 1,000/mcL
  • Total bilirubin =< 1.5 X institutional upper limit of normal (ULN) (unless documented Gilbert’s Syndrome, for which bilirubin =< 3 x institutional ULN is permitted)
  • Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 2.5 X institutional ULN (up to 5 times ULN in presence of liver metastases)
  • Creatinine =< 2 x normal institutional limits OR creatinine clearance >= 45 mL/min/1.73 m^2 for patients with creatinine levels above institutional normal
  • Patients must have an electrocardiogram (ECG) within 8 weeks prior to registration to screening step and must have NONE of the following cardiac criteria: * Resting corrected QT interval (QTc) > 480 msec ** NOTE: If the first recorded QTc exceeds 480 msec, two additional, consecutive ECGs are required and must result in a mean resting QTc =< 480 msec; it is recommended that there are 10-minute (+/- 5 minutes) breaks between the ECGs * The following only need to be assessed if the mean QTc >480 msec ** Check potassium and magnesium serum levels ** Correct any identified hypokalemia and/or hypomagnesemia and may repeat ECG to confirm exclusion of patient due to QTc ** For patients with heart rate (HR) 60-100 bpm, no manual read of QTc is required ** For patients with baseline HR < 60 or > 100 bpm, manual read of QT by trained personnel is required, with Fridericia correction applied to determine QTc * No factors that increase the risk of QTc prolongation or risk of arrhythmic events such as heart failure, hypokalemia, congenital long QT syndrome, family history of long QT syndrome or unexplained sudden death under 40 years of age or any concomitant medication known to prolong the QT interval ** NOTE: Patient must be taken off medication prior to screening; patient must be off the drug for at least 5 half-lives prior to registration to the treatment; the medication half-life can be found in the package insert for Food and Drug Administration (FDA) approved drugs
  • Patients with multiple myeloma are not eligible; NOTE: Once validation of the screening assay multiple myeloma specimens is completed, the protocol will be formally amended to allow inclusion of patients with multiple myeloma

Copyright © 2026 KRM Digital Solutions